Here’s an update that prompted Timber Pharmaceuticals, Inc. (TMBR) shares surge in the late hours
Timber Pharmaceuticals, Inc. (NYSE American: TMBR), the stock was up 20.57% to $1.06in the extended-hours session. The Company focuses on the development and commercialization of treatments for rare and orphan dermatologic diseases. Years of clinical experience and well-established CMC and safety profiles have resulted in the Company’s investigational therapies possessing proven mechanisms-of-action. Get the hottest […]